• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BMT
Click for more information
11.8% 19.0¢

BEAMTREE HOLDINGS LIMITED - News & Media

Market Cap $54.62M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Beamtree Holdings Limited is an Australia-based artificial intelligence decision support... Beamtree Holdings Limited is an Australia-based artificial intelligence decision support and data company. The Company provides automation technology and data analytics that support health care providers. The Company's segments include diagnostic technology, clinical decision support, coding assistance and data quality, analytics and knowledge networks. The diagnostic technology segment includes its RippleDown products, which automate decision making in clinical and administrative processes in pathology. Its automation of clinical record coding and data integrity products include its RippleDown and Performance Indicators for Coding Quality coding technologies (PICQ). Its clinical decision support segment includes Ainsoff Deterioration Index, which is a machine learning-based tool that predicts the risk of patient deterioration and alerts clinicians in real time. Its products also include advisory and auditing, Q coding platform, and Relative Indicators for Safety and Quality.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
19.0¢ 		Change
0.020(11.8%) 		Mkt cap ! $54.62M
Open High Low Value Volume
16.5¢ 19.0¢ 16.5¢ $50.57K 281.6K

Buyers (Bids)

No. Vol. Price($)
1 5001 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 21893 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
18.0¢ 		  Change
0.020 ( 2.86 %)
Open High Low Volume
18.0¢ 19.0¢ 18.0¢ 51861
Last updated 15.08pm 26/04/2024 ?
BMT (ASX) Chart

Top Stories

Recce Pharmaceuticals up 6% on new antibiotic production milestone

Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Lithium Universe reveals plan to fill a 'gap' in the North American market Lithium Universe has flagged its Québec Lithium Processing Hub in Canada as a key producer of battery-grade lithium to the North American market..
1970s on repeat, but there's a silver lining! ABBA fans across Australia know that the 1970s were not only about nervous shuffles to the strains of Dancing Queen, across the linoleum floor at the local Blue Light Disco. Oil had only recently begun to rise, and so synthetic fabrics, like polyester, were very popular. So was central heating, using fuel oil. This is all ancient history now and it would not matter except for the fact that history is now rhyming so hard.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy The big thematics and headlines that drove the ASX this week, plus, the headlines I think investors ought to be keeping eyes on.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.